Market Cap 10.50B
Revenue (ttm) 6.78B
Net Income (ttm) 711.50M
EPS (ttm) N/A
PE Ratio 15.46
Forward PE 16.30
Profit Margin 10.49%
Debt to Equity Ratio 0.67
Volume 7,360,579
Avg Vol 10,478,856
Day's Range N/A - N/A
Shares Out 681.74M
Stochastic %K 78%
Beta 0.98
Analysts Sell
Price Target $14.66

Company Profile

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 610 386 1700
Address:
Radnor Corporate Center, Building One Suite 200 100 Matsonford Road, Radnor, United States
OptionRunners
OptionRunners Oct. 27 at 3:04 PM
$AVTR Buyer of the November 21st $16 puts (ITM) 1,000 times for $1.68-$1.75 ahead of earnings on 10/29
0 · Reply
JarvisFlow
JarvisFlow Oct. 24 at 12:13 PM
Baird updates rating for Avantor ( $AVTR ) to Outperform, target set at 15 → 17.
0 · Reply
RunnerSignals
RunnerSignals Oct. 21 at 3:39 AM
$AVTR $EW $GPOR $HTO.X $ORC crossing above 200-day MAs! Golden crosses everywhere you look
0 · Reply
dudebob
dudebob Oct. 17 at 7:23 PM
~50,000 $KODK for the pharma precursors play. Long & strong 💪 Thoughts $DJT $AVTR $JNJ $TEVA ? Is this a foolish move, or a decent long term play?
0 · Reply
ZacksResearch
ZacksResearch Oct. 17 at 4:53 PM
$AVTR partners with BlueWhale Bio — a promising step for CAR-T therapy? 🤔 Despite shares being down 30.8% YTD, this strategic move could enhance Avantor's role in cell therapy, leveraging its bioprocessing strength and BlueWhale's CDNP technology to streamline production and drive long-term growth. 📈 Discover the full potential here 👉 https://www.zacks.com/stock/news/2771361/avantor-partners-with-bluewhale-bio-to-advance-car-t-manufacturing?cid=sm-stocktwits-2-2771361-body-16643&ADID=SYND_STOCKTWITS_TWEET_2_2771361_BODY_16643
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 17 at 4:17 PM
Enter: $AVTR NOV 21 2025 $14 CALLS Buy in Price: $1.10 - $1.80 Take Profit: $1.87 Stop Bleeding: $0.97 ROI Potential: 70% Exit Within: 2 Weeks https://moneygroup.us/alerts
0 · Reply
ZacksResearch
ZacksResearch Oct. 17 at 3:53 PM
$AVTR teaming up with BlueWhale Bio — a big move in the CAR-T space. 💥 The partnership uses CDNP tech to accelerate manufacturing, scale production, and widen patient access — strong strategic alignment. See what this means for Avantor’s growth path 👉 https://www.zacks.com/stock/news/2771361/avantor-partners-with-bluewhale-bio-to-advance-car-t-manufacturing?cid=sm-stocktwits-2-2771361-teaser-16634&ADID=SYND_STOCKTWITS_TWEET_2_2771361_TEASER_16634
0 · Reply
SilverEagle
SilverEagle Oct. 16 at 4:14 PM
$AVTR yeeeet
0 · Reply
JarvisFlow
JarvisFlow Oct. 16 at 4:10 PM
Raymond James updates rating for Avantor ( $AVTR ) to Outperform, target set at 14 → 16.
0 · Reply
SilverEagle
SilverEagle Oct. 9 at 9:13 PM
$AVTR bottomed?
0 · Reply
Latest News on AVTR
Avantor® Announces Board Chairman Transition

Oct 13, 2025, 4:05 PM EDT - 13 days ago

Avantor® Announces Board Chairman Transition


Avantor® Reiterates Shareholder Value Creation Focus

Aug 11, 2025, 9:33 AM EDT - 2 months ago

Avantor® Reiterates Shareholder Value Creation Focus


Activist Investor to Push Avantor to Sell Itself

Aug 10, 2025, 6:00 PM EDT - 2 months ago

Activist Investor to Push Avantor to Sell Itself


Avantor, Inc. (AVTR) Q2 2025 Earnings Call Transcript

Aug 1, 2025, 10:42 AM EDT - 3 months ago

Avantor, Inc. (AVTR) Q2 2025 Earnings Call Transcript


Avantor® Reports Second Quarter 2025 Results

Aug 1, 2025, 6:05 AM EDT - 3 months ago

Avantor® Reports Second Quarter 2025 Results


Avantor Announces Emmanuel Ligner as Next President and CEO

Jul 21, 2025, 7:05 AM EDT - 3 months ago

Avantor Announces Emmanuel Ligner as Next President and CEO


Avantor Analysts Cut Their Forecasts After Q1 Results

Apr 28, 2025, 9:28 AM EDT - 6 months ago

Avantor Analysts Cut Their Forecasts After Q1 Results


Avantor: A Healthier Diagnosis As Expectations Cool

Apr 26, 2025, 5:01 AM EDT - 6 months ago

Avantor: A Healthier Diagnosis As Expectations Cool


Avantor, Inc. (AVTR) Q1 2025 Earnings Call Transcript

Apr 25, 2025, 10:53 AM EDT - 6 months ago

Avantor, Inc. (AVTR) Q1 2025 Earnings Call Transcript


Avantor® Announces CEO Transition

Apr 25, 2025, 6:07 AM EDT - 6 months ago

Avantor® Announces CEO Transition


Avantor® Reports First Quarter 2025 Results

Apr 25, 2025, 6:05 AM EDT - 6 months ago

Avantor® Reports First Quarter 2025 Results


Avantor, Inc. (AVTR) Q4 2024 Earnings Call Transcript

Feb 7, 2025, 11:08 AM EST - 9 months ago

Avantor, Inc. (AVTR) Q4 2024 Earnings Call Transcript


Avantor® Reports Fourth Quarter and Full Year 2024 Results

Feb 7, 2025, 6:05 AM EST - 9 months ago

Avantor® Reports Fourth Quarter and Full Year 2024 Results


Avantor: Durable FCF Generator Trading For Cheap

Dec 18, 2024, 4:15 AM EST - 11 months ago

Avantor: Durable FCF Generator Trading For Cheap


Avantor Inc. (AVTR) Q3 2024 Earnings Call Transcript

Oct 25, 2024, 2:52 PM EDT - 1 year ago

Avantor Inc. (AVTR) Q3 2024 Earnings Call Transcript


Avantor® Reports Third Quarter 2024 Results

Oct 25, 2024, 6:05 AM EDT - 1 year ago

Avantor® Reports Third Quarter 2024 Results


OptionRunners
OptionRunners Oct. 27 at 3:04 PM
$AVTR Buyer of the November 21st $16 puts (ITM) 1,000 times for $1.68-$1.75 ahead of earnings on 10/29
0 · Reply
JarvisFlow
JarvisFlow Oct. 24 at 12:13 PM
Baird updates rating for Avantor ( $AVTR ) to Outperform, target set at 15 → 17.
0 · Reply
RunnerSignals
RunnerSignals Oct. 21 at 3:39 AM
$AVTR $EW $GPOR $HTO.X $ORC crossing above 200-day MAs! Golden crosses everywhere you look
0 · Reply
dudebob
dudebob Oct. 17 at 7:23 PM
~50,000 $KODK for the pharma precursors play. Long & strong 💪 Thoughts $DJT $AVTR $JNJ $TEVA ? Is this a foolish move, or a decent long term play?
0 · Reply
ZacksResearch
ZacksResearch Oct. 17 at 4:53 PM
$AVTR partners with BlueWhale Bio — a promising step for CAR-T therapy? 🤔 Despite shares being down 30.8% YTD, this strategic move could enhance Avantor's role in cell therapy, leveraging its bioprocessing strength and BlueWhale's CDNP technology to streamline production and drive long-term growth. 📈 Discover the full potential here 👉 https://www.zacks.com/stock/news/2771361/avantor-partners-with-bluewhale-bio-to-advance-car-t-manufacturing?cid=sm-stocktwits-2-2771361-body-16643&ADID=SYND_STOCKTWITS_TWEET_2_2771361_BODY_16643
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 17 at 4:17 PM
Enter: $AVTR NOV 21 2025 $14 CALLS Buy in Price: $1.10 - $1.80 Take Profit: $1.87 Stop Bleeding: $0.97 ROI Potential: 70% Exit Within: 2 Weeks https://moneygroup.us/alerts
0 · Reply
ZacksResearch
ZacksResearch Oct. 17 at 3:53 PM
$AVTR teaming up with BlueWhale Bio — a big move in the CAR-T space. 💥 The partnership uses CDNP tech to accelerate manufacturing, scale production, and widen patient access — strong strategic alignment. See what this means for Avantor’s growth path 👉 https://www.zacks.com/stock/news/2771361/avantor-partners-with-bluewhale-bio-to-advance-car-t-manufacturing?cid=sm-stocktwits-2-2771361-teaser-16634&ADID=SYND_STOCKTWITS_TWEET_2_2771361_TEASER_16634
0 · Reply
SilverEagle
SilverEagle Oct. 16 at 4:14 PM
$AVTR yeeeet
0 · Reply
JarvisFlow
JarvisFlow Oct. 16 at 4:10 PM
Raymond James updates rating for Avantor ( $AVTR ) to Outperform, target set at 14 → 16.
0 · Reply
SilverEagle
SilverEagle Oct. 9 at 9:13 PM
$AVTR bottomed?
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Oct. 9 at 3:49 PM
Results for list 9/26/25 $AVT $AVTR $AVXL $AVY 🔥 Cycle Trading Signal plugged into AI 🔥
0 · Reply
T_L808
T_L808 Oct. 8 at 1:58 PM
$AVTR daily chart this time, nice pattern under ytd vwap
0 · Reply
Winning_calls
Winning_calls Oct. 6 at 1:27 AM
$AVTR pick me up @ $14.30
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 4 at 4:02 AM
Enter: $AVTR NOV 21 2025 $14 CALLS Buy in Price: $0.95 - $1.00 Take Profit: $1.61 Stop Bleeding: $0.84 ROI Potential: 70% Exit Within: 360 Minutes https://moneygroup.us/alerts
1 · Reply
T_L808
T_L808 Oct. 3 at 3:43 PM
$AVTR watching @ $15.34
0 · Reply
JarvisFlow
JarvisFlow Oct. 2 at 2:04 PM
Barclays has updated their rating for Avantor ( $AVTR ) to Overweight with a price target of 15.
0 · Reply
healthcareguru
healthcareguru Sep. 30 at 2:04 AM
Healthcare M&A Takeout / Must-Own Basket: $AXGN $AVTR $ADMA $EVH $SGRY 🔥💪👍💵
1 · Reply
SQUEAKSBANDIT
SQUEAKSBANDIT Sep. 29 at 12:36 AM
$AVTR one word- oversold will be interesting to see how the activist investor scenario plays out
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Sep. 26 at 5:22 AM
Enter: $AVTR OCT 17 2025 $13 CALLS Buy in Price: $0.25 - $0.35 Take Profit: $0.57 Stop Bleeding: $0.22 ROI Potential: 130% Exit Within: 295 Minutes https://moneygroup.us/alerts
0 · Reply
DarthWallstreet
DarthWallstreet Sep. 24 at 5:42 PM
$AVTR Add here if you like $!!
0 · Reply
DarthWallstreet
DarthWallstreet Sep. 24 at 5:29 PM
$AVTR I’m betting this is the bottom. Then again my great grandfather bet the Titanic wouldn’t sink. Getting calls from my loan shark Freddy the Forehead, this better pop soon!!!
0 · Reply
healthcareguru
healthcareguru Sep. 24 at 2:11 PM
$EVH getting ready to sell themselves to a strategic, clearly…deleveraging, FCF improving, guidance derisked. MUST OWN M&A Basket!! 🔥💪💵 $ADMA $AXGN $AVTR $SGRY
1 · Reply